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Abstract Haemophilus influenzae, Streptococcus pyoge-
nes, Moraxella catarrhalis, Staphylococcus aureus, and
Streptococcus pneumoniae are usual cause of upper respi-
ratory tract infection cases. The present study aims the
isolation of bacterial strains which are resistant to the
commonly prescribed antibiotics. In total, 900 throat swabs
were obtained from the patients suffering from upper res-
piratory tract infections residing in three different locali-
ties. The maximum number of isolates (64 %) were
obtained from locality-1 (L-1), whereas lowest isolates
were found in second locality (L-2). H. influenzae was
found to be the most dominant bacterial pathogen in upper
respiratory tract infections in patients with 42 % of the
total isolates. H. influenzae and Chlamydia pneumoniae
were resistant to b-lactam antibiotics but susceptible to
fluroquinolones and aminoglycosides, whereas S. aureus
and S. pneumoniae were found to be highly resistant to b-
lactam, aminoglycosides and fluroquinolones. S. aureus
was also moderately resistant to fluroquinolones and
aminoglycosides with percent resistance of 26, 33 and
18 %, respectively. 56 % S. pneumoniae isolates were
resistant against erythromycin, 27 % against chloram-
phenicol and 23 % against cefuroxime. The studies
revealed that S. aureus and S. pneumoniae strains were
high producer of biofilms which could be one of the rea-
sons for their high pathogenicity.
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Introduction
Upper respiratory tract infections are one of the common
diseases which can be found in the individuals of all age
groups. Pharyngitis, nasopharyngitis, tonsillitis, otitis
media and sinusitis are the major infections of upper res-
piratory tract. These major problems are generally caused
by viruses (rhinovirus, adenovirus, parainfluenza virus,
human metapneumovirus, and influenza virus. After the
viral invasion, the secondary infection is caused by various
types of bacteria resulting in chronic obstructive lung dis-
ease and high fever. The different types of bacteria which
are involved in upper respiratory tract infections (RTIs) are
Haemophilus influenzae, Streptococcus pyogenes, Mo-
raxella catarrhalis, Staphylococcus aureus, and Strepto-
coccus pneumonia. Although the upper respiratory tract
infection cases are not complicated, the acute swelling
caused by these infections may threaten airway patency
resulting in asthmatic condition or cause obstruction in the
passage of ingestion which further leads to significant
dehydration. The RTIs are more common in developing
countries in which, after diarrhea, RTIs are the second
cause of death in children due to pneumonia (Ndip et al.
2009). Each year, United States reports that mortality rate
of *14 % (5.6 million cases) is directly associated with
community-acquired pneumonia (CAP) (Karchmer 2004).
Bacteria are becoming resistant to conventional antibi-
otics. Ten years ago, concern centered on Gram-positive
bacteria, particularly methicillin-resistant S. aureus and
vancomycin-resistant Enterococcus spp (Kumarasamy
et al. 2010). Now, however, large number of clinical
& Li-min Wang
wlmwanglimin@hotmail.com
1 Department of Clinical Laboratory, Women and Infants
Hospital of Zhengzhou, No. 41, Jinshui Road, Jinshui
District, Zhengzhou, Henan 450012, People’s Republic of
China
123
3 Biotech (2016) 6:166
DOI 10.1007/s13205-016-0473-z
microbiologists agree that multidrug-resistant Gram-nega-
tive bacteria pose the greatest risk to public health (Ukpai
et al. 2015). The increase in resistance of Gram-negative
bacteria (faster than in Gram-positive bacteria) is higher
than active new/developmental antibiotics, and only a few
drug development programs are insufficient to provide
therapeutic cover in next 10–20 years. The main reason for
increase in resistance from antibiotics in bacteria is due to
the mobile genes present on the plasmids which spread and
transfer through bacterial populations (Bennett 2009). The
overuse and misuse of antibiotics for the treatment of
respiratory tract infection has been considered one of the
major reasons for the emergence of resistance of bacteria
against antibiotics (Gonzales et al. 1997). Another reason
for antibiotic resistance of bacteria has been considered to
be the production of biofilms during quorum-sensing-reg-
ulated mechanism which releases beta-lactamase respon-
sible for degradation of various antibiotics (Wilke et al.
2005). It has been reported that S. pneumoniae were found
to be resistant to penicillin and erythromycin, H. influenzae
were resistant from ampicillin, whereas S. pyogenes iso-
lates were resistant from erythromycin (Karchmer 2004).
Nowadays, the resistance of bacteria against existing
antibiotics has been at alarming stage throughout the world
with high mortality rate due to acute infections by various
bacteria in respiratory infections in China, so more studies
are required to isolate the novel bacterial strains resistant to
various antibiotics. The pool of isolated resistant bacteria
will be used to develop the potential strategy so as to target
the regulation of bacterial resistance mechanisms to
enhance the potency of available drugs, restore the efficacy
of available drugs and develop the new range of antibiotics
specific to new mechanism of drug resistance (Lister et al.
2009). In the present study, attempts were made to isolate
the bacterial species from the infected persons of different
age groups residing in different localities in China which




Sterilized swabs were purchased from Fisher scientific
(UK); Blood agar and eosin methylene blue agar were
purchased from Sigma Aldrich (USA); for biochemical
tests, API 20E kit was purchased from Biomerieux
(France) and Mueller–Hinton plates were purchased from
Biotech (England). All other laboratory reagents were
purchased from Merck-Millipore Chemicals.
Experimental designs and subjects
The studies were conducted in Guangdong Province,
China. The province is thickly populated and is about
1902 m above the sea level. Average daily temperature in
Guangzhou in January and July are 18 and 33 C, respec-
tively, with high humidity. The favorable temperature and
relatively high humidity are mainly responsible for the
respiratory tract infections.
The study was conducted on three different localities
and three different age groups. The first group was having
subjects with age ranging 5–25 years, which were mainly
students studying in schools and colleges. The second
group was 26–45 years age group which consists of
working-class people and the third age group was ranging
46–65-year-old people. Totally, 900 subjects were selec-
ted (300 persons in each locality), and each locality
includes 155 males and 145 female subjects. The subjects
were informed prior about the aim of study, and their
verbal consent was solicited. All the subjects were
assured regarding privacy of disease and data. The three
different localities were designated as L-1, L-2 and L-3.
The different age groups, i.e., 5–25 years, 26–45 years
and 46–65 year were designated as X, Y and Z, respec-
tively. All the subjects included in the study were having
symptoms of sore throat, cough, running nose, and the
study was conducted between March 2014 and October
2014.
Isolation of bacterial strains
Three hundred throat swabs from individuals of different
age groups were taken in the sterilized plastic sample bags
for the study. The samples were collected between
6 months (March 2014–August 2014) which included both
dry and wet seasons which is favorable for the growth and
invasion of various microorganisms.
The swabs were aseptically inoculated on the Petri
plates containing blood agar media, and the plates were
incubated at 37 C in incubator for 24 h. After incubation,
the morphological as well as microscopic examination of
the colonies was done. The colonies obtained on the petri
plates were subcultured on solid media several times to get
the pure culture of the microorganisms. When the pure
cultures were obtained, the microorganisms were subcul-
tured on the solid media in slants and preserved at 4 C for
further investigations. Microorganisms in pure culture were
identified on the basis of their morphological characteris-
tics on selective and differential media. API 20E kits were
used for biochemical testing to confirm the identity of
microorganisms.
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Antibiotic susceptibility test
Antibiotic susceptibility test using microbroth dilution
method was used to investigate the antibiotic susceptibility/
resistance of isolates (Hendriksen 2003; Tilton et al. 1973).
In brief, the test was carried out in a 96-well microtiter
plate by distributing 240 lL of sterile media and 30 lL of
antibiotic stock (5 mg mL-1) giving concentration of
500 lg mL-1; 150 lL from first well was transferred to the
next and was diluted with sterile medial with factor of 2.
Dilution up to 10 wells were giving the range of
500–0.197 lg mL-1, and appropriate blanks (to have a
check on sterility) and controls (to see the growth-favoring
ability of media) were also taken. To each well (except
blank), 10 lL of isolated and identified bacterial inocula
(107 cells mL-1) were added, and plate was incubated in
rotary shaker incubator 150 rpm, 30 C for 36 h. The
qualitative observation of turbidity was carried out with
naked eyes under light and dark background and compared
with clear blank well and hazy control well to make a
decision of growth. The minimum inhibitory concentration
(MIC) of particular antibiotic against particular organism
was defined as lowest concentration where no viability of
bacteria was observed in the wells of 96-microwell plates
after incubation of 36 h.
Detection of biofilm formation
Most of the antibiotic-resistant bacteria form biofilms
during their growth and metabolism which are responsible
for their resistance against many antibiotics. Two different
biofilm formation analysis tests were performed. First test
was based on the colorimetric detection of crystal violet-
stained bacteria which is also known as tissue culture plate
test (TCP) (Stepanovic et al. 2007). Another method for
detection of biofilm was used which was based on the
Congo red dye test (Freeman et al. 1989). In brief, the stock
strain was transferred to Mueller–Hinton agar and was
incubated for 24 h, 37 C. Purified strain culture was
resuspended in phosphate buffer pH 7.0 50 mM and diluted
appropriately to get turbidity equivalent to 0.5 McFarland
standard, i.e., 108 CFU/mL. Sterile tryptic soy broth sup-
plemented with 2.5 % glucose was taken for inoculation of
isolated bacteria and were incubated for 24 ± 0.5 h at
37 C with no shaking. Gentle washing was done with
300 lL phosphate buffer (pH 7.0, 50 mM) five times.
Biofilm fixation was done through 150 lL methanol
exposure for 15 min. The wall-fixed biofilm-containing
bacteria was stained with 200 lL of 2 % crystal violet.
After 15 min exposure, rest of the stain was removed and
washed with buffer till no dye appeared in the wash. The
well plate is dried at room temperature; then, the
dried,stained,wall-fixed biofilm is solubilized by 95 %
ethanol for 30 min, and OD was measured at 570.
Results
Bacterial isolates
The dominated species of pathogenic bacteria in three
different localities of Guangdong Province of China has
been presented in Table 1. From the various inoculated
samples, 59 % of the samples examined were positive for
infectious microorganisms. The four dominated species of
pathogenic bacteria were identified as H. influenzae, S.
aureus, S. pneumoniae and Chlamydia pneumonia. Each
isolate/strain was given a code with respect to the species,
e.g., H.I.1 for first isolate/strain of H. influenza and simi-
larly for other species. Among four bacterial species, the
highest number (23 %) of isolates of H. influenzae were
obtained, whereas lowest number (8 %) were obtained of
C. pneumoniae, whereas S. aureus and S. pneumoniae
contributed 15 and 13 % of total isolates, respectively. It
was observed that the maximum (64 %) number of isolates
were obtained from locality-1 (L-1), whereas lowest iso-
lates were found in the second locality (L-2).
It was observed that among three different age groups,
the maximum isolates (51.03 %) were obtained from the
age group of 5–25 years among which 42 % of isolates
were H. influenzae as shown in Table 2.
Antibiotic susceptibility test
Microbroth dilution method was used to test the suscepti-
bility of isolated microorganisms against different antibi-
otics such as ampicillin, amoxyclav, ciprofloxacin,
chloramphenicol, erythromycin, cefuroxime and gentam-
icin ranging from (0.02–64 lg/mL), and criteria for sug-
gesting whether the isolate is susceptible or resistant
toward specific antibiotic have been given in Table 3. It
was observed that the H. influenzae was highly resistant to
ampicillin (43 % resistant strains) and erythromycin (41 %
resistant strains), whereas it was least resistant to cipro-
floxacin (9 % resistant strains) and gentamicin (12 %
resistant strains) (Table 4).
Staphylococcus aureus was resistant to b-lactam
antibiotics such as ampicillin, amoxyclav as well as mar-
colide antibiotics such as erythromycin with percent
resistance of 65, 46 and 54 %, respectively (Table 4). S.
aureus was also moderately resistant to fluroquinolone
antibiotics such as ciprofloxacin, chloramphenicol and
aminoglycosides antibiotics such as gentamicin with per-
cent resistance of 26, 33 and 18 %, respectively.
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In this study, S. pneumoniae was observed to be 56 %
resistant against erythromycin, 27 % against chloram-
phenicol and 23 % against cefuroxime (Table 4). It was
observed that comparative to other isolates, S. pneumoniae
was even 42 and 21 % resistant against ciprofloxacin and
gentamicin which were found to be highly sensitive
antibiotics against other isolates. C. pneumoniae was
observed to be highly resistant against chloramphenicol
and erythromycin compared to other antibiotics; it was
having 57 and 63 % resistance against chloramphenicol
and erythromycin, respectively (Table 4).
Biofilm production test
Many pathogenic microorganisms form a slimy layer
during invasion and infections which is basically termed
as biofilm. All isolates were studied for biofilm produc-
tion using tissue culture plate (TCP) test and Congo red
dye test. Purple-bluish color was observed in the tissue
culture plate wells when stained with gram stain. The
organisms which produced dark purple-bluish color in
tissue culture wells were considered as strong biofilm-
producing strains, the bacteria with light purple-bluish
color stained in wells were considered as moderate bio-
film-producing strains, whereas the bacteria which were
not stained in the wells were considered as no biofilm-
producing strains (Fig. 1a).
It was observed that among four major isolates, S.
aureus and S. pneumoniae were found positive for biofilm
production. S. pneumoniae and S. aureus strains were
observed to produce strong biofilms, whereas few strains
of H. influenzae and C. pneumoniae were producing
moderate biofilms with light purple color staining in the
micro-titre plate wells and maximum strains were found
to be negative for biofilm production with no purple color
staining in the tissue culture plate wells. The strong and
moderate biofilm-producing strains were further tested by
Congo red dye test method in Petri plates. It was observed
that the strong biofilm-producing S.A.11 strain of S.
aureus and S.P.5 strain of S. pneumoniae were observed
to produce dark black-colored colonies in congo red plate
indicating strong biofilms production, whereas C.P.24
strain of C. pneumoniae and H.I.98 strain of H. influenzae
which have shown moderate biofilm production in TCP
test were able to produce black-colored colonies in congo
red dye plate indicating no biofilm production (Fig. 1b).
The SEM images of S. aureus and S. pneumoniae in
Fig. 1c clearly showed the biofilm production in these
strains.
Discussion
From the results in Table 1, it was observed that the
maximum (64 %) number of isolates was obtained from
locality-1 (L-1), whereas lowest isolates were found in
second locality (L-2). The possible reason for maximum
isolates from L-1 could be the unhygienic living standards
as well as damp and humid environment which were the
favorable conditions for the growth and development of
various pathogens. Moreover, the locality was thickly
populated which had also increased the risk of communi-
cable infections.
Table 1 Different bacterial isolates in three different localities




Haemophilus influenzae L-1 78 26
L-2 45 15
L-3 86 28.66
Staphylococcus aureus L-1 41 13.66
L-2 55 18.33
L-3 38 12.66
Streptococcus pneumoniae L-1 46 15.33
L-2 32 10.66
L-3 40 13.33




Table 2 Percentage of bacterial isolates found in three different age groups
Bacterial species Age groups (years)
5–25 26–45 46–65 Total
Isolates (no.) % Isolates (no.) % Isolates (no.) % Isolates (no.) %
Haemophilus influenzae 126 42 23 7.6 60 20 209 23.22
Staphylococcus aureus 63 21 30 10 41 13.66 134 14.88
Streptococcus pneumoniae 50 16.66 38 12.66 40 13.33 118 13.11
Chlamydia pneumoniae 32 10.66 18 6 20 6.6 70 7.77
Total 271 51.03 109 20.52 161 30.32 531 59
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Table 2 shows bacterial isolates found in three different
age groups, and depicts that H. influenzae was the most
dominant during secondary respiratory tract infections in
children. This age group included mostly the school/col-
lege going children. Many students were found to be
underweight, malnourished and debilitated due to which
they were having lower immunity and more vulnerable to
the respiratory infections. The minimum isolates (20.52 %)
were obtained from the age group of 26–45 years among
which the 12.66 % isolates were S. pneumoniae as this age
group was basically composed of the healthy adults
working in hygienic conditions and found to have good
immunity against infections. In the age group of
46–65 years which was mostly composed of old-age per-
sons, 30.32 % of isolates were obtained with 20 % of H.
influenzae.
Antibiotic susceptibility studies showed H. influenzae to
be highly resistant to ampicillin and erythromycin, how-
ever, it was least resistant to ciprofloxacin and gentamicin.
It has been reported that in H. influenzae, the resistance
from ampicillin and amoxicillin was mediated by TEM-1
b-lactamase enzyme (Rennie and Ibrahim 2005). In pre-
vious studies, chloramphenicol was considered as the best
antibiotic against H. influenzae, but few studies in north
India revealed no resistance from this drug (Puri et al.
1999). Ampicillin inhibits the cell wall synthesis of bac-
teria by binding to penicillin-binding proteins (PBPs) so,
maybe due to mutations or environmental changes in
bacteria, ampicillin was not able to bind with the PBPs
resulting in bacterial resistance to ampicillin (Sharma et al.
2013). Also, erythromycin was not able to inhibit the
growth of H. influenzae even at higher concentrations
which might be due to some protective mechanism that it
developed against erythromycin. Few studies had also
reported H. influenzae resistance toward ciprofloxacin due
to mutations in the quinolone resistance-determining
regions (QRDRs) of gyrA and parC (Brenwald et al. 2003).
Ciprofloxacin inhibits the bacterial replication, transcrip-
tion and repair by inactivating topoisomerase II (DNA
gyrase) and topoisomerase IV enzymes. But in this study,
H. influenzae showed no resistance against ciprofloxacin.
Along with ciprofloxacin, gentamicin was also found to be
effective against H. influenzae strains due to its irreversible
binding to 30S units of bacterial ribosomes which inhibits
its protein synthesis. Ciprofloxacin and gentamicin both
were reported to be susceptible for H. influenzae in previ-
ous studies (Zanchi et al. 1994).
On the other hand, S. aureus was resistant to b-lactam
antibiotics as well as marcolide antibiotics. Although S.
aureus has broad-spectrum resistance against different
class of antibiotics such as b-lactams, glycopeptides, qui-
nolones, aminoglycosides, oxazolidinones, quinupristin–
dalfopristin due to presence of various resistance genes
(Lowy 2003), in another study, S. aureus was found to be
resistant against methicillin antibiotics due to presence of
mec and ccr genes (Chambers and Deleo 2010); but in this
study, ciprofloxacin, chloramphenicol and gentamicin were
found to be highly susceptible for S. aureus with low
resistance. Due to the horizontal gene transfer of complex
genetic array of mec element or vanA operon, it became
resistant to different types of antibiotics (Pantosti et al.
2007). Cefuroxime was having moderate effect on S. aur-
eus with 61 % sensitivity.
S. pneumoniae is a major causative agent in respiratory
tract infections in humans, and they were once highly
penicillin-susceptible microorganisms, but recently, they
Table 3 Interpretation of susceptible or resistant bacteria and the
accepted range of MIC for the E. coli ATCC 25922 reference strain









Ampicillin (AMP) B4 C16 4
Amoxyclav (AMC) B1 C4 1
Amoxicillin (AMO) B64 C128 64
Ciprofloxacin (CIP) B0.08 C0.32 0.08
Chloramphenicol (CHL) B4 C16 4
Erythromycin (ERY) B0.2 C0.8 0.2
Cefuroxime (CEF) B4 C16 4
Gentamicin (GEN) B0.2 C0.8 0.2
Table 4 Antibiotic resistance test of different bacterial isolates with different antibiotics
Isolates and number tested No. of isolates resistant to antibiotics
Ampicillin Amoxyclav Ciprofloxacin Chloramphenicol Erythromycin Cefuroxime Gentamicin
Haemophilus influenzae (209) 90 (43 %) 48 (23 %) 25 (12 %) 56 (27 %) 85 (41 %) 32 (15 %) 18 (9 %)
Staphylococcus aureus (134) 87 (65 %) 62 (46 %) 35 (26 %) 44 (33 %) 72 (54 %) 52 (39 %) 24 (18 %)
Streptococcus pneumoniae (118) 63 (53 %) 45 (38 %) 50 (42 %) 32 (27 %) 66 (56 %) 27 (23 %) 25 (21 %)
Chlamydia pneumoniae (70) 40 (57 %) 16 (23 %) 12 (17 %) 38 (54 %) 44 (63 %) 12 (17 %) 14 (20 %)
Total 280 (53 %) 171 (32 %) 122 (23 %) 170 (32 %) 267 (50 %) 123 (23 %) 81 (15 %)
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were found to be multidrug-resistant (Tomasz 1997). S.
pneumoniae has been found to be responsible for estimated
one million deaths each year in children below 5 years
(Obaro et al. 1996). Susceptibility of S. pneumoniae was
studied in Canada, and it was observed that ciprofloxacin
was having poor potency against S. pneumoniae (Patel
et al. 2011). After 10 years of use in United States, the
susceptibility of ciprofloxacin was examined with S.
pneumoniae, and the MIC was observed to be increased
due to bacterial resistance (Sahm et al. 2000).
C. pneumoniae was observed to be highly resistant
against chloramphenicol and erythromycin in this study. In
previous studies, it was observed that C. pneumoniae is
susceptible to erythromycin, azithromycin, roxithromycin,
clarithromycin, doxycycline, ofloxacin, and rifampin, and
their combination is more lethal (Freidank et al. 1999)
which was in agreement with our study.
Conclusion
The study revealed that various pathogenic bacteria in
respiratory tract infection had become resistant to wide
range of commonly used antibiotics. H. influenzae was the
major causative agent for respiratory infections found in all
age groups as its maximum number of isolates was
obtained in the present study. Although considerable per-
centage of all isolates were observed to be resistant to
various antibiotics, S. aureus and S. pneumoniae were
found to be highly resistant to strong antibiotics like
ciprofloxacin and gentamicin which might be due to the
presence of resistant genetic elements present in these
strains. The emergence of highly resistant bacteria against
the commonly prescribed antibiotics is at alarming level;
therefore, novel antibiotics should be introduced for severe
respiratory tract infections. Moreover, different antibiotics
in combination can be helpful against various resistant
pathogenic strains.
In few studies, H. influenzae has been reported to pro-
duce strong biofilm (Galli et al. 2007; Mizrahi et al. 2014),
but in the present study, strong biofilm production in H.
influenzae strains was not observed. One of the possible
reasons for biofilm production in various bacteria is quo-
rum sensing. Quorum sensing in S. aureus was found to be
responsible for the production of biofilms during various
infections, and gene regulator agr was found to play
important role in its biofilm production (Yarwood et al.
2004). The production of biofilms in bacteria has been
reported to enhance the bacterial resistance against
antibiotic, for example, production of biofilms in S. aureus
was responsible for its resistance against methicillin
(McCarthy et al. 2015). In another study, 60.47 % of S.
aureus were found to be biofilm producers when tested
with crystal violet test method, while 13.95 % of strains
were found to be biofilm producer when tested with congo
red agar (CRA) test method (Elkhatib et al. 2014) which
showed high variability in these two methods which is in
Fig. 1 Tissue culture plate (TCP) test for biofilm production in
bacterial isolates (a), Congo red dye test for biofilm production in
isolates (b) and SEM images of biofilm produced in (i) S. aureus and
(ii) S. pneumoniae (c)
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agreement with our study. In previous studies, S. pneu-
moniae was also observed to be good producer of biofilm
during respiratory tract infections (Moscoso et al. 2006)
which is in agreement with this study.
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